BCL2 and non-small cell lung carcinoma: The observation that these agents affect the expression of multiple prosurvival proteins in NSCLC also explains the relatively broad efficacy that they have in this tumor type, which is known to exhibit a heterogeneous dependency on BCL-2 family proteins (28).